Predictors of early mortality and effectiveness of antiretroviral therapy in TB-HIV patients from Brazil

por Demitto, Fernanda O., Schmaltz, Carolina A. S., Sant’Anna, Flávia M., Arriaga, María B., Andrade, Bruno B., Rolla, Valeria C.
Publicado 2019

Impact of adverse drug reactions on the outcomes of tuberculosis treatment

por Sant´Anna, Flávia M., Araújo-Pereira, Mariana, Schmaltz, Carolina A. S., Arriaga, María B., Andrade, Bruno B., Rolla, Valeria C.
Publicado 2023

Tuberculosis Treatment Outcomes and Factors Associated with Each of Them in a Cohort Followed Up between 2010 and 2014

por Cardoso, Mayara A., do Brasil, Pedro Emmanuel A. A., Schmaltz, Carolina Arana Stanis, Sant'Anna, Flavia M., Rolla, Valeria C.
Publicado 2017

T Cell Activation and Cytokine Profile of Tuberculosis and HIV-Positive Individuals during Antituberculous Treatment and Efavirenz-Based Regimens

por da Silva, Tatiana P., Giacoia-Gripp, Carmem B. W., Schmaltz, Carolina A., Sant` Anna, Flavia M., Rolla, Valeria, Morgado, Mariza G.
Publicado 2013

Impact of Persistent Anemia on Systemic Inflammation and Tuberculosis Outcomes in Persons Living With HIV

por Demitto, Fernanda O., Araújo-Pereira, Mariana, Schmaltz, Carolina A., Sant’Anna, Flávia M., Arriaga, María B., Andrade, Bruno B., Rolla, Valeria C.
Publicado 2020

Daily 800 mg versus 600 mg Efavirenz for HIV Patients Treating Tuberculosis with a Rifampicin-Based Regimen: An Open Label Randomized Controlled Trial

por Xavier, Mariana S., Trajman, Anete, Schmaltz, Carolina A. S., Sant'anna, Flavia M., Maia, Ivan R., Hadad, David J., do Brasil, Pedro Emmanuel A. A., Rolla, Valeria
Publicado 2018